Frequently Asked Questions

NovaGenesis is an independent, research-focused knowledge base for peptide science. We compile peer-reviewed data, mechanism breakdowns, and protocol context for 17+ documented compounds — written for researchers, clinicians, and serious students of pharmacology.

No. NovaGenesis is an educational resource only. We do not sell, supply, or recommend vendors. All content is provided strictly for research and informational purposes.

No. Nothing on NovaGenesis constitutes medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any health-related decision.

Most compounds documented here are classified as research chemicals and are not approved for human use by the FDA. A small subset (e.g., tirzepatide, semaglutide) have approved clinical formulations under specific brand names and indications.

Research-use-only (RUO) materials are intended exclusively for in vitro or laboratory investigation by qualified personnel. They are not manufactured, tested, or labeled for human or veterinary administration.

Prioritize peer-reviewed primary literature (PubMed-indexed) over secondary commentary. Look for clearly stated methodology, sample size, dosing regimens, and statistical analysis. Every compound page on NovaGenesis links directly to its source citations.

Lyophilized (freeze-dried) peptides are typically stable at -20°C for 12–24 months when sealed and protected from moisture. Always reference the certificate of analysis (CoA) for compound-specific stability data.

Most reconstituted peptides remain stable for 14–28 days at 2–8°C (refrigerated) when prepared with bacteriostatic water. Stability varies significantly by sequence — fragile peptides like BPC-157 degrade faster than stable analogues like semaglutide.

Sterile water contains no preservatives and is intended for single-use reconstitution. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits microbial growth and allows multi-dose use over ~28 days.

Use our reconstitution calculator at /calculator. Enter the peptide mass (mg), desired dose (mcg), and syringe unit size to get the exact diluent volume needed.

Insulin syringes in 0.3 mL (30-unit) and 1 mL (100-unit) capacities are the most common in published protocols, with 29–31 gauge needles. Smaller volumes improve dose-measurement precision.

GLP-1 / GIP / glucagon co-agonists dominate the current literature — primarily semaglutide, tirzepatide, and retatrutide. All three are profiled in our Peptide Library with citation-backed mechanism breakdowns.

BPC-157 is a synthetic pentadecapeptide derived from gastric juice protein, studied for localized tissue repair and angiogenesis. TB-500 is a synthetic fragment of thymosin beta-4, studied for systemic actin regulation and broader regenerative signaling.

SS-31 (elamipretide) is a mitochondrial-targeted tetrapeptide studied for cardioprotection, bioenergetic rescue in age-related decline, and rare mitochondrial disease models. See its full profile in our library.